Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Maternal, Child Health Lag Behind Other Millennium Development Goals, Study Finds
Despite signs of progress in the treatment of HIV/AIDS, malaria and childhood diseases, efforts to reduce maternal and newborn health as part of the U.N. Millennium Development Goals (MDGs) lag behind, according to the 2009 Report of the Global Campaign for the Health Millennium Development Goals released Monday, Inter Press Service reports.

Prostate Cancer Gene 3 (PCA3): Development And Internal Validation Of A Novel Biopsy Nomogram
UroToday.com - In this paper, we investigated 809 prostate cancer patients subjected to >10 cores at initial or repeat prostate biopsy from two prospective, multi-center studies from Europe and North America It has been demonstrated that the urinary marker Prostate CAncer gene 3 (PCA3) represents a novel prostate cancer (PCa) detection marker capable of increasing accuracy of multivariable biopsy nomograms.[1] The paper reports the first PCA3-based nomograms which accurately identify individuals at risk of harboring PCa (AUC=0.73). If a PCA3 score in combination with established risk factors is available, this novel tool assists clinicians in deciding whether further prostatic evaluation is necessary.
News of the day
Data Published In The New England Journal Of Medicine Support Use Of Raxibacumab (ABthrax(TM)) For The Treatment Of Inhalation Anthrax
Human Genome Sciences, Inc. (Nasdaq: HGSI) announced publication by The New England Journal of Medicine of the results of two pivotal animal efficacy studies, which showed the life-saving potential of the Company"s human monoclonal antibody drug raxibacumab (ABthrax(TM)), as well as the results of human safety studies, which supported the use of raxibacumab in the event of life-threatening inhalation anthrax disease.
Medical Devices

RCN Responds To Publication Of Lord Darzi's Progress Report

Responding to the publication of Lord Darzi"s report, High Quality Care for All: Our Journey So Far, Dr Peter Carter, Chief Executive & General Secretary of the Royal College of Nursing (RCN), said: "Nurses have always strived to deliver quality care and welcomed Lord Darzi"s vision for how clinical staff could achieve this. It has been a significant achievement that since the publication of the NHS review a year ago, everybody is talking about how quality of patient care should take centre stage in the NHS. However, in the tough economic climate we must not take our eye off the ball and let the focus on quality slip. If we are to make quality a reality rather than an aspiration, it is vital that nurses are empowered and given the right level of support. "We have always said clinical leadership is key to driving up patient care and welcome the news that nurses are set to have greater control over budgets. Their frontline perspective means nurses know where money should be spent to achieve the best care for patients. However, adequate support and training for these professionals is needed, particularly while the threat of public spending cuts looms. "While there have been significant improvements in the NHS, there are certain areas where further work is needed. There needs to be greater clarification regarding the practicalities of what delivering care closer to home would look like. Patients want to know exactly what services will be available in the area they call home." "If genuine improvements to the NHS are to be achieved, significant progress towards delivering Darzi"s promises must be made, and the new ways of working must be embedded, before the financial pressures take hold." Royal College of Nursing


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009